FDA Clears United Therapeutics to Proceed With SUMMIT Trial
United Therapeutics said the FDA cleared its investigational new drug application to proceed with the phase 2 SUMMIT trial of treprostinil SMI in PH-COPD.
United Therapeutics said the FDA cleared its investigational new drug application to proceed with the phase 2 SUMMIT trial of treprostinil SMI in PH-COPD.